Stockreport

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single- [Read more]